The control of male sexual responses.
Male sexual responses are reflexes mediated by the spinal cord and modulated by neural circuitries involving both the peripheral and central nervous system. While the brain interact with the reflexes to allow perception of sexual sensations and to exert excitatory or inhibitory influences, penile reflexes can occur despite complete transections of the spinal cord, as demonstrated by the reviewed animal studies on spinalization and human studies on spinal cord injury. Neurophysiological and neuropharmacological substrates of the male sexual responses will be discussed in this review, starting with the spinal mediation of erection and its underlying mechanism with nitric oxide (NO), followed by the description of the ejaculation process, its neural mediation and its coordination by the spinal generator of ejaculation (SGE), followed by the occurrence of climax as a multisegmental sympathetic reflex discharge. Brain modulation of these reflexes will be discussed through neurophysiological evidence involving structures such as the medial preoptic area of hypothalamus (MPOA), the paraventricular nucleus (PVN), the periaqueductal gray (PAG), and the nucleus para-gigantocellularis (nPGI), and through neuropharmacological evidence involving neurotransmitters such as serotonin (5-HT), dopamine and oxytocin. The pharmacological developments based on these mechanisms to treat male sexual dysfunctions will complete this review, including phosphodiesterase (PDE-5) inhibitors and intracavernous injections (ICI) for the treatment of erectile dysfunctions (ED), selective serotonin reuptake inhibitor (SSRI) for the treatment of premature ejaculation, and cholinesterase inhibitors as well as alpha adrenergic drugs for the treatment of anejaculation and retrograde ejaculation. Evidence from spinal cord injured studies will be highlighted upon each step.
Université du Québec à Montréal, Département de Sexologie, CP 8888, Succursale Centre-Ville, Montréal, Québec, H3C 3P8, Canada. courtois.frederique@uqam.ca
Frédérique
F
Courtois
Serge
S
Carrier
Kathleen
K
Charvier
Pierre A
PA
Guertin
Nicolas Morel
NM
Journel
D000818:Animals; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D010410:Penile Erection / Q000187:drug effects / Q000502:physiology; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D012018:Reflex / Q000187:drug effects / Q000502:physiology; D012725:Sexual Behavior / Q000187:drug effects* / Q000502:physiology / Q000523:psychology; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology
D018377:Neurotransmitter Agents; D058986:Phosphodiesterase 5 Inhibitors; D009569:Nitric Oxide